Corvus Pharmaceuticals, Inc. (CRVS)
NASDAQ: CRVS · Real-Time Price · USD
8.88
+0.64 (7.71%)
Nov 21, 2024, 2:49 PM EST - Market open
Corvus Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 555 | 86 | 40 | 112 | 100 | 160 | |
| Market Cap Growth | 361.98% | 118.11% | -64.73% | 12.29% | -37.55% | 48.85% | |
| Enterprise Value | 474 | 56 | -7 | 40 | 51 | 77 | |
| Last Close Price | 8.24 | 1.76 | 0.85 | 2.41 | 3.56 | 5.44 | |
| PB Ratio | 41.56 | 2.23 | 0.71 | 1.15 | 1.38 | 2.25 | |
| P/TBV Ratio | 26.62 | 2.23 | 0.71 | 1.15 | 1.38 | 2.25 | |
| Debt / Equity Ratio | 0.03 | 0.04 | 0.05 | 0.04 | 0.03 | 0.04 | |
| Quick Ratio | 0.90 | 3.96 | 3.99 | 7.22 | 3.65 | 7.66 | |
| Current Ratio | 0.92 | 4.07 | 4.06 | 7.36 | 3.73 | 7.76 | |
| Return on Equity (ROE) | -200.48% | -57.02% | -53.90% | -51.08% | -8.37% | -51.44% | |
| Return on Assets (ROA) | -28.30% | -25.63% | -22.50% | -24.61% | -32.33% | -30.25% | |
| Return on Capital (ROIC) | -53.35% | -29.52% | -25.06% | -27.38% | -36.77% | -33.07% | |
| Earnings Yield | -10.33% | -31.32% | -104.39% | -38.55% | -6.00% | -29.18% | |
| FCF Yield | -4.02% | -27.77% | -68.97% | -32.73% | -34.89% | -23.35% | |
| Buyback Yield / Dilution | -18.45% | -3.16% | -11.23% | -41.98% | -0.44% | -6.69% | |
| Total Shareholder Return | -18.45% | -3.16% | -11.23% | -41.98% | -0.44% | -6.69% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.